Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoseph Barash

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Leukemia|October 9, 2019
Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19Mukta Asnani, Katharina E Hayer, Ammar S Naqvi, et al.
Nature Communications|September 22, 2022
High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistanceMariela Cortés-López, Laura Schulz, Mihaela Enculescu, et al.
Plos Genetics|January 10, 2020
Genomic profiling of human vascular cells identifies TWIST1 as a causal gene for common vascular diseasesSylvia T Nurnberg, Marie A Guerraty, Robert C Wirka, et al.
Cell Reports|December 24, 2016
A SLM2 Feedback Pathway Controls Cortical Network Activity and Mouse BehaviorIngrid Ehrmann, Matthew R Gazzara, Vittoria Pagliarini, et al.
Blood Cancer Discovery|January 11, 2022
Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed ImmunotherapiesSisi Zheng, Elisabeth Gillespie, Ammar S Naqvi, et al.
Blood|September 8, 2023
Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapiesZhiwei Ang, Luca Paruzzo, Katharina E Hayer, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapiesZhiwei Ang, Luca Paruzzo, Katharina E Hayer, et al.
RNA (New York, N.Y.)|October 10, 2023
Extensible benchmarking of methods that identify and quantify polyadenylation sites from RNA-seq dataSam Bryce-Smith, Dominik Burri, Matthew R Gazzara, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Extensible benchmarking of methods that identify and quantify polyadenylation sites from RNA-seq dataSam Bryce-Smith, Dominik Burri, Matthew R Gazzara, et al.
Cell Reports|August 9, 2025
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomasPriyanka Sehgal, Ammar S Naqvi, Makenna Higgins, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Leukemia|October 9, 2019
Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19Mukta Asnani, Katharina E Hayer, Ammar S Naqvi, et al.
Nature Communications|September 22, 2022
High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistanceMariela Cortés-López, Laura Schulz, Mihaela Enculescu, et al.
Plos Genetics|January 10, 2020
Genomic profiling of human vascular cells identifies TWIST1 as a causal gene for common vascular diseasesSylvia T Nurnberg, Marie A Guerraty, Robert C Wirka, et al.
Cell Reports|December 24, 2016
A SLM2 Feedback Pathway Controls Cortical Network Activity and Mouse BehaviorIngrid Ehrmann, Matthew R Gazzara, Vittoria Pagliarini, et al.
Blood Cancer Discovery|January 11, 2022
Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed ImmunotherapiesSisi Zheng, Elisabeth Gillespie, Ammar S Naqvi, et al.
Blood|September 8, 2023
Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapiesZhiwei Ang, Luca Paruzzo, Katharina E Hayer, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapiesZhiwei Ang, Luca Paruzzo, Katharina E Hayer, et al.
RNA (New York, N.Y.)|October 10, 2023
Extensible benchmarking of methods that identify and quantify polyadenylation sites from RNA-seq dataSam Bryce-Smith, Dominik Burri, Matthew R Gazzara, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Extensible benchmarking of methods that identify and quantify polyadenylation sites from RNA-seq dataSam Bryce-Smith, Dominik Burri, Matthew R Gazzara, et al.
Cell Reports|August 9, 2025
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomasPriyanka Sehgal, Ammar S Naqvi, Makenna Higgins, et al.
Pageof 9